Export 10 results:
Author Title [ Type
Filters: Author is Ferreira, Jennifer [Clear All Filters]
“Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.”, J Infect Dis, vol. 202, no. 11, pp. 1649-58, 2010.
, “B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.”, Clin Vaccine Immunol, vol. 24, no. 5, 2017.
, “Determination of the 50% human infectious dose for Norwalk virus.”, J Infect Dis, vol. 209, no. 7, pp. 1016-22, 2014.
, “Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.”, J Infect Dis, vol. 211, no. 6, pp. 870-8, 2015.
, “Norovirus vaccine against experimental human Norwalk Virus illness.”, N Engl J Med, vol. 365, no. 23, pp. 2178-87, 2011.
, “A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults.”, J Infect Dis, vol. 210, no. 11, pp. 1763-71, 2014.
, “Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.”, JAMA, vol. 311, no. 17, pp. 1760-9, 2014.
, “Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.”, J Infect Dis, vol. 208, no. 5, pp. 728-38, 2013.
, “Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females.”, J Pediatric Infect Dis Soc, vol. 2, no. 1, pp. 7-14, 2013.
, “Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males.”, Clin Infect Dis, vol. 51, no. 10, pp. e76-81, 2010.
,